Terms: = Lymphoma AND PR, PGR, progesterone receptor AND Clinical Outcome
36 results:
1. Selinexor With Anti-PD-1 Antibody as a Potentially Effective Regimen for Patients With Natural Killer/T-Cell lymphoma Failing Prior L-Asparaginase and PD-1 Blockade.
Tao R; Liu C; Zhang W; Zhu Y; Ma Y; Hao S
Oncologist; 2024 Jan; 29(1):e90-e96. PubMed ID: 37616529
[TBL] [Abstract] [Full Text] [Related]
2. clinical Efficacy of Bendamustine Plus Rituximab (BR) for B-cell Relevant Indolent Non-Hodgkin's lymphoma and Role of
Zhang Y; He D; He J; Huang W; Yang Y; Cai Z; Zhao Y
Comput Math Methods Med; 2022; 2022():1080879. PubMed ID: 35096126
[TBL] [Abstract] [Full Text] [Related]
3. Open-label, single arm, multicenter phase II study of VIDL induction chemotherapy followed by upfront autologous stem cell transplantation in patients with advanced stage extranodal NK/T-cell lymphoma.
Song GY; Yoon DH; Suh C; Moon JH; Baek DW; Kim JS; Lee GW; Yi JH; Park Y; Jung KS; Kim SJ; Yang DH; Kim WS
Bone Marrow Transplant; 2021 May; 56(5):1205-1208. PubMed ID: 33277620
[TBL] [Abstract] [Full Text] [Related]
4. Activity of ibrutinib plus R-CHOP in diffuse large B-cell lymphoma: Response, pharmacodynamic, and biomarker analyses of a phase Ib study.
Schaffer M; Chaturvedi S; Davis C; de Jong J; Aquino R; Oki Y; Fourneau N; Younes A; Balasubramanian S
Cancer Treat Res Commun; 2020; 25():100235. PubMed ID: 33188997
[TBL] [Abstract] [Full Text] [Related]
5. [Long-term clinical outcome of children and adolescents with Burkitt's lymphoma treated with rituximab combined with modified NHL-BFM-90 regimen].
Li YX; Yin QS; Ai H; Mi RH; Zhang LN; Li YF; Wei XD; Song YP
Zhonghua Yi Xue Za Zhi; 2019 Feb; 99(8):605-610. PubMed ID: 30818930
[No Abstract] [Full Text] [Related]
6. Crizotinib treatment for patients with EGFR mutation positive NSCLC that acquire cMET amplification after EGFR TKI therapy results in short-lived and heterogeneous responses.
van Veggel B; de Langen AJ; Hashemi S; Monkhorst K; Rosenberg EH; Heideman DAM; Radonic T; Smit EF
Lung Cancer; 2018 Oct; 124():130-134. PubMed ID: 30268451
[TBL] [Abstract] [Full Text] [Related]
7. A prospective phase II trial of response adapted whole brain radiotherapy after high dose methotrexate based chemotherapy in patients with newly diagnosed primary central nervous system lymphoma-analysis of acute toxicity profile and early clinical outcome.
Adhikari N; Biswas A; Gogia A; Sahoo RK; Garg A; Nehra A; Sharma MC; Bhasker S; Singh M; Sreenivas V; Chawla R; Joshi G; Kumar L; Chander S
J Neurooncol; 2018 Aug; 139(1):153-166. PubMed ID: 29633112
[TBL] [Abstract] [Full Text] [Related]
8. Unilesional plantar mycosis fungoides treated with topical photodynamic therapy - case report and review of the literature.
Kaufmann F; Kettelhack N; Hilty N; Kempf W
J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):1633-1637. PubMed ID: 28168737
[TBL] [Abstract] [Full Text] [Related]
9. Immunotherapy with the trifunctional anti-CD20 x anti-CD3 antibody FBTA05 (Lymphomun) in paediatric high-risk patients with recurrent CD20-positive B cell malignancies.
Schuster FR; Stanglmaier M; Woessmann W; Winkler B; Siepermann M; Meisel R; Schlegel PG; Hess J; Lindhofer H; Borkhardt A; Buhmann R
Br J Haematol; 2015 Apr; 169(1):90-102. PubMed ID: 25495919
[TBL] [Abstract] [Full Text] [Related]
10. A therapeutic trial of decitabine and vorinostat in combination with chemotherapy for relapsed/refractory acute lymphoblastic leukemia.
Burke MJ; Lamba JK; Pounds S; Cao X; Ghodke-Puranik Y; Lindgren BR; Weigel BJ; Verneris MR; Miller JS
Am J Hematol; 2014 Sep; 89(9):889-95. PubMed ID: 24891274
[TBL] [Abstract] [Full Text] [Related]
11. [Clinicopathological characteristics and prognostic analysis of 92 cases with primary gastrointestinal diffuse large B-cell lymphoma].
Feng J; Wan W; Wan W; Wang J; Jing H; Wang J; Zhao W; Liu Y; Ke X
Zhonghua Xue Ye Xue Za Zhi; 2014 Apr; 35(4):288-94. PubMed ID: 24759013
[TBL] [Abstract] [Full Text] [Related]
12. Bevacizumab and cyclosphosphamide, doxorubicin, vincristine and prednisone in combination for patients with peripheral T-cell or natural killer cell neoplasms: an Eastern Cooperative Oncology Group study (E2404).
Ganjoo K; Hong F; Horning SJ; Gascoyne RD; Natkunam Y; Swinnen LJ; Habermann TM; Kahl BS; Advani RH
Leuk Lymphoma; 2014 Apr; 55(4):768-72. PubMed ID: 23786456
[TBL] [Abstract] [Full Text] [Related]
13. Management of hairy cell leukemia variant.
Robak T
Leuk Lymphoma; 2011 Jun; 52 Suppl 2():53-6. PubMed ID: 21599606
[TBL] [Abstract] [Full Text] [Related]
14. Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study.
Pott C; Hoster E; Delfau-Larue MH; Beldjord K; Böttcher S; Asnafi V; Plonquet A; Siebert R; Callet-Bauchu E; Andersen N; van Dongen JJ; Klapper W; Berger F; Ribrag V; van Hoof AL; Trneny M; Walewski J; Dreger P; Unterhalt M; Hiddemann W; Kneba M; Kluin-Nelemans HC; Hermine O; Macintyre E; Dreyling M
Blood; 2010 Apr; 115(16):3215-23. PubMed ID: 20032498
[TBL] [Abstract] [Full Text] [Related]
15. Splenectomy with chemotherapy vs surgery alone as initial treatment for splenic marginal zone lymphoma.
Milosevic R; Todorovic M; Balint B; Jevtic M; Krstic M; Ristanovic E; Antonijevic N; Pavlovic M; Perunicic M; Petrovic M; Mihaljevic B
World J Gastroenterol; 2009 Aug; 15(32):4009-15. PubMed ID: 19705496
[TBL] [Abstract] [Full Text] [Related]
16. Anti-idiotype antibody response after vaccination correlates with better overall survival in follicular lymphoma.
Ai WZ; Tibshirani R; Taidi B; Czerwinski D; Levy R
Blood; 2009 Jun; 113(23):5743-6. PubMed ID: 19346494
[TBL] [Abstract] [Full Text] [Related]
17. Detection of t(14;18), P53 and RAS gene mutations and quantification of residual disease in patients with B-cell non-Hodgkin's lymphoma.
Cikota BM; Tukić LJ; Tarabar OT; Magić ZM
J Exp Clin Cancer Res; 2007 Dec; 26(4):535-42. PubMed ID: 18365550
[TBL] [Abstract] [Full Text] [Related]
18. Consolidation and maintenance immunotherapy with rituximab improve clinical outcome in patients with B-cell chronic lymphocytic leukemia.
Del Poeta G; Del Principe MI; Buccisano F; Maurillo L; Capelli G; Luciano F; Perrotti AP; Degan M; Venditti A; de Fabritiis P; Gattei V; Amadori S
Cancer; 2008 Jan; 112(1):119-28. PubMed ID: 17999417
[TBL] [Abstract] [Full Text] [Related]
19. Peripheral T-cell lymphoma, unspecified--the analysis of the data from the Czech lymphoma Study Group (CLSG) registry.
Prochazka V; Trneny M; Pytlik R; Vasova I; Kral Z; Belada D; Kozak T; Kubackova K; Siffnerova H; Matuska M; Lysy M; Bolomska I; Petrakova K; Otavova B; Pribylova J; Svecova J; Papajik T; Hamouzova M; Petrova M; Zapletalova J; Langova K
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2007 Jun; 151(1):103-7. PubMed ID: 17690750
[TBL] [Abstract] [Full Text] [Related]
20. [Primary breast lymphoma--a report of 27 cases with literature review].
Cao YB; Wang SS; Huang HQ; Xu GC; He YJ; Guan ZZ; Lin TY
Ai Zheng; 2007 Jan; 26(1):84-9. PubMed ID: 17222374
[TBL] [Abstract] [Full Text] [Related]
[Next]
